144 related articles for article (PubMed ID: 31372587)
1. Successful Management Of Tumor-Induced Osteomalacia with Radiofrequency Ablation: A Case Series.
Mishra SK; Kuchay MS; Sen IB; Garg A; Baijal SS; Mithal A
JBMR Plus; 2019 Jul; 3(7):e10178. PubMed ID: 31372587
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Gallium-68 DOTANOC PET/CT Guided Radiofrequency Ablation in the Treatment of Tumor-induced Osteomalacia.
Sharma J; Kasliwal R; Jain T; Sharma GK
JCEM Case Rep; 2024 May; 2(5):luae044. PubMed ID: 38660485
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients.
Jadhav S; Kasaliwal R; Shetty NS; Kulkarni S; Rathod K; Popat B; Kakade H; Bukan A; Khare S; Budyal S; Jagtap VS; Lila AR; Bandgar T; Shah NS
J Clin Endocrinol Metab; 2014 Sep; 99(9):3049-54. PubMed ID: 24960541
[TBL] [Abstract][Full Text] [Related]
5. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
Hesse E; Moessinger E; Rosenthal H; Laenger F; Brabant G; Petrich T; Gratz KF; Bastian L
J Bone Miner Res; 2007 Jan; 22(1):158-62. PubMed ID: 17014386
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficiency of
He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
[TBL] [Abstract][Full Text] [Related]
8. Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET/CT.
Naswa N; Sharma P; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2013 Aug; 38(8):639-40. PubMed ID: 23531775
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance and impact on patient management of
Paquet M; Gauthé M; Zhang Yin J; Nataf V; Bélissant O; Orcel P; Roux C; Talbot JN; Montravers F
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Follow-Up Data of Tumor-Induced Osteomalacia Managed with Surgery and/or Radiofrequency Ablation from a Single Center.
Memon SS; Patel MA; Lila A; Jadhav S; Sarathi V; Karlekar M; Barnabas R; Patil V; Kulkarni S; Rathod K; Shah N; Bandgar T
Calcif Tissue Int; 2024 Jun; ():. PubMed ID: 38922426
[TBL] [Abstract][Full Text] [Related]
11. Tumor(s) induced osteomalacia--a curious case of double trouble.
Sahoo J; Balachandran K; Kamalanathan S; Das AK; Patro DK; Halanaik D; Badhe B
J Clin Endocrinol Metab; 2014 Feb; 99(2):395-8. PubMed ID: 24297794
[TBL] [Abstract][Full Text] [Related]
12. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
[TBL] [Abstract][Full Text] [Related]
13. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
14. Phosphaturic Tumor-Induced Osteomalacia.
Ashouri D; Kastoon T
Cureus; 2024 Feb; 16(2):e54712. PubMed ID: 38389570
[TBL] [Abstract][Full Text] [Related]
15. Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients.
Ho CL
Nucl Med Mol Imaging; 2015 Sep; 49(3):231-6. PubMed ID: 26279697
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced osteomalacia.
Florenzano P; Gafni RI; Collins MT
Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
18. A Case of Tumor-Induced Osteomalacia: Finding the Culprit Acetabular Tumor and Successful Resection with a Novel Hip Joint-Preserving Surgery.
Turin CG; Wilson RJ; Mangone C; Rosenspire K; Berman J; Walker M; Amaravadi R; Al Mukaddam M
J Orthop Case Rep; 2021 Mar; 11(3):37-41. PubMed ID: 34239825
[TBL] [Abstract][Full Text] [Related]
19. 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.
Zhang J; Zhu Z; Zhong D; Dang Y; Xing H; Du Y; Jing H; Qiao Z; Xing X; Zhuang H; Li F
Clin Nucl Med; 2015 Aug; 40(8):642-6. PubMed ID: 26053726
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
